HS-20094 Injection
Sponsors
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Conditions
ObesityOverweightType 2 Diabetes
Phase 3
A Study of HS-20094 in Chinese Adults With Overweight or Obesity
CompletedNCT06839664
Start: 2024-11-16End: 2026-01-30Updated: 2026-06-08
A Phase 3 Study of HS-20094 in Patients With T2DM
Not yet recruitingNCT07156539
Start: 2025-09-30End: 2027-05-30Target: 546Updated: 2025-09-05
A Phase 3 Study of HS-20094 in Patients With T2DM Inadequately Controlled With Diet and Exercise Alone
Not yet recruitingNCT07156500
Start: 2025-09-30End: 2027-05-30Target: 204Updated: 2025-09-05